[1]
“Informative Censoring in CDK4/6 Inhibitor Adjuvant Therapy for Early Breast Cancer: A Sensitivity Analysis of Invasive Disease-Free Survival in the monarchE Trial”, ebph, Sep. 2025, doi: 10.54103/2282-0930/29562.